XDNE:F:F-db x-trackers JPX-Nikkei 400 UCITS DR 3C (EUR)

ETF | Others |

Last Closing

USD 27.315

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

1.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.10%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.60 (+0.25%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUSA:F Vanguard Funds Public Limited ..

+0.24 (+0.24%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.28 (+0.28%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

-3.78 (-2.48%)

USD 37.92B

ETFs Containing XDNE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.64% 74% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.64% 70% C- 61% D-
Trailing 12 Months  
Capital Gain 23.12% 70% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.12% 66% D+ 58% F
Trailing 5 Years  
Capital Gain 84.29% 89% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.29% 89% A- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 16.11% N/A N/A 80% B-
Dividend Return 16.11% N/A N/A 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.43% N/A N/A 75% C
Risk Adjusted Return 104.36% N/A N/A 96% N/A
Market Capitalization 0.04B 14% F 23% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.